Busilvex er blevet undersøgt hos patienter, hovedsagelig med blodkræft, som havde behov for transplantation af bloddannende progenitorceller.
Busilvex has been studied in patients, mainly with blood cancer, who needed transplantation of haematopoietic progenitor cells.